MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
19.79
+1.28 (6.92%)
Mar 9, 2026, 4:00 PM EDT - Market closed
MapLight Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 864 | - | - | - |
| Enterprise Value | 643 | - | - | - |
| Debt / Equity Ratio | 0.03 | 0.06 | 0.08 | 0.30 |
| Net Debt / Equity Ratio | -0.95 | -0.89 | -1.04 | -1.02 |
| Net Debt / EBITDA Ratio | 2.05 | 1.24 | 1.30 | 0.70 |
| Net Debt / FCF Ratio | 1.96 | 1.28 | 1.41 | 0.78 |
| Quick Ratio | 12.24 | 6.83 | 5.43 | 2.20 |
| Current Ratio | 13.22 | 7.20 | 5.69 | 2.54 |
| Return on Equity (ROE) | - | -83.21% | -120.91% | - |
| Return on Assets (ROA) | - | -45.41% | -54.74% | - |
| Return on Capital Employed (ROCE) | -45.50% | -68.60% | -74.70% | -116.60% |
| Buyback Yield / Dilution | -15.66% | -11.60% | -18.43% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.